To avoid the potential effect of FOXP3+ TILs, we selected the CD25low tumors, indicative of few FOXP3+ TILs, to assess the association between expression of FOXP3 and miR-200 s in the TCGA breast cancers (Additional file 1: Figure S2C). This evidence concerns the gene FOXP3 and breast carcinoma.